Title:
RHEUMATOID ARTHRITIS AUTO-ANTIBODY-BOUND PEPTIDE AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/151631
Kind Code:
A1
Abstract:
The present invention provides a peptide capable of binding with rheumatoid arthritis auto-antibody, having antigen decision sites bound with rheumatoid arthritis auto-antibody. Further provided is a method for detection of rheumatoid arthritis diseases using the peptide.
Inventors:
TSAY GREGORY (CN)
PENG HSIN-YI (CN)
PENG HSIN-YI (CN)
Application Number:
PCT/CN2020/073097
Publication Date:
July 30, 2020
Filing Date:
January 20, 2020
Export Citation:
Assignee:
UNIV CHINA MEDICAL (CN)
International Classes:
C07K7/08; C07K14/195; G01N33/68
Domestic Patent References:
| WO2012001103A1 | 2012-01-05 |
Foreign References:
| CN104987366A | 2015-10-21 | |||
| CN104262489A | 2015-01-07 | |||
| US20170269078A1 | 2017-09-21 |
Other References:
PARK MIN; PYUN JAE-CHUL; AKTER HAFEZA; NGUYEN BINH THANH; KANG MIN-JUNG: "Evaluation of a specific diagnostic marker for rheumatoidarthritis based on cyclic citrullinated peptide", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 115, 25 June 2015 (2015-06-25), pages 107 - 113, XP029272830
Attorney, Agent or Firm:
WINGUAN PATENT AND TRADEMARK ATTORNEYS (CN)
Download PDF:
Previous Patent: LIGHT-EMITTING DEVICE AND STAGE LAMP SYSTEM
Next Patent: ROUTE PLANNING METHOD AND DEVICE FOR ASSISTED PARKING
Next Patent: ROUTE PLANNING METHOD AND DEVICE FOR ASSISTED PARKING